Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

p48/64 MW HPC in Aneurysm Occlusion (PIANO): Prospective, Multicenter, Single-arm Clinical Trial to Determine Safety and Effectiveness of the Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms.

NCT07143019 is registered in ClinicalTrials.gov with phenox Inc. as lead sponsor.

NCT NCT07143019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07143019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
p48/64 MW HPC in Aneurysm Occlusion (PIANO): Prospective, Multicenter, Single-arm Clinical Trial to Determine Safety and Effectiveness of the Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms.
Lead sponsor
phenox Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
March 16, 2026
Completion date
July 31, 2032
Enrollment
214 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysm, intracranial, brain aneurysm, fusiform aneurysm, hemorrhagic stroke, saccular aneurysm